Literature DB >> 525953

[Ecology of leishmaniasis in the south of France. 10. Developmental stages and clinical characterization of canine leishmaniasis in relation to epidemiology. (author's transl)].

G Lanotte, J A Rioux, J Perieres, Y Vollhardt.   

Abstract

In an analytical study of a focus of leishmaniasis in Southern France (Cévennes), a clinical, parasitological and immunological comparison was made of dogs with natural and experimental infections of leishmaniasis. Observations were made in longterm laboratory experiments and on dogs found infected in field surveys. Two main clinical forms, patent and latent, were apparent. The latent form could be further subdivided into two types namely preclinical (the commonor: about 90%) and resolving (about 10%). The epidemiological periods, can result on the maintenance of the parasites for several years without the need for transmission by the vector. The prevalence and duration of the different forms of disease in dogs are thought to be of great importance in the epidemiology of leishmaniasis in foci in which canids are reservoir hosts.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525953

Source DB:  PubMed          Journal:  Ann Parasitol Hum Comp        ISSN: 0003-4150


  19 in total

1.  Diagnostic techniques to detect cryptic leishmaniasis in dogs.

Authors:  Laura Iniesta; Salceda Fernández-Barredo; Béatrice Bulle; M Teresa Gómez; Renaud Piarroux; Montserrat Gállego; José M Alunda; Montserrat Portús
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

2.  Introduction of an improved direct agglutination test for the detection of Leishmania infantum infection in southern France.

Authors:  P M de Korte; A E Harith; J Dereure; E Huigen; V Faucherre; H J van der Kaay
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

3.  Phlebotomine sandflies and factors associated with their abundance in the leishmaniasis endemic area of Attiki, Greece.

Authors:  Sofia Boutsini; Labrini V Athanasiou; Gregory Spanakos; Dimitra Ntousi; Eleni Dotsika; Marina Bisia; Elias Papadopoulos
Journal:  Parasitol Res       Date:  2017-11-10       Impact factor: 2.289

4.  Incidence and time course of Leishmania infantum infections examined by parasitological, serologic, and nested-PCR techniques in a cohort of naive dogs exposed to three consecutive transmission seasons.

Authors:  Gaetano Oliva; Aldo Scalone; Valentina Foglia Manzillo; Marina Gramiccia; Annalisa Pagano; Trentina Di Muccio; Luigi Gradoni
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

5.  Distribution and relationships between clinical and biopathological parameters in canine leishmaniasis.

Authors:  I Amusategui; A Sainz; F Rodríguez; M A Tesouro
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

6.  Detection of anti-Leishmania immunoglobulin G antibodies in urine specimens of dogs with leishmaniasis.

Authors:  L Solano-Gallego; A Rodríguez; L Iniesta; M Arboix; M Portús; J Alberola
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

7.  Toward diagnosing Leishmania infantum infection in asymptomatic dogs in an area where leishmaniasis is endemic.

Authors:  D Otranto; P Paradies; D de Caprariis; D Stanneck; G Testini; F Grimm; P Deplazes; G Capelli
Journal:  Clin Vaccine Immunol       Date:  2009-01-07

8.  Application of a direct agglutination test for detection of specific anti-Leishmania antibodies in the canine reservoir.

Authors:  A el Harith; R J Slappendel; I Reiter; F van Knapen; P de Korte; E Huigen; A H Kolk
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

9.  Serological diagnosis of leishmaniasis: on detecting infection as well as disease.

Authors:  C Dye; E Vidor; J Dereure
Journal:  Epidemiol Infect       Date:  1993-06       Impact factor: 2.451

10.  Culling dogs in scenarios of imperfect control: realistic impact on the prevalence of canine visceral leishmaniasis.

Authors:  Danielle N C C Costa; Cláudia T Codeço; Moacyr A Silva; Guilherme L Werneck
Journal:  PLoS Negl Trop Dis       Date:  2013-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.